AUA: Atenolol Linked to Drop in Low-, Intermediate-Risk Prostate Cancer
FRIDAY, May 3, 2019 -- Atenolol is associated with a reduction in incident intermediate- and low-risk prostate cancer (PCa), according to a study presented at the annual meeting of the American Urological Association, held from May 3 to 6 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Atenolol | Cancer | Cancer & Oncology | Pharmaceuticals | Prostate Cancer | Study | Urology & Nephrology